|1.||Antonioli, Luca: 1 article (11/2010)|
|2.||Colucci, Rocchina: 1 article (11/2010)|
|3.||Awwad, Oriana: 1 article (11/2010)|
|4.||Duranti, Emiliano: 1 article (11/2010)|
|5.||Blandizzi, Corrado: 1 article (11/2010)|
|6.||Fornai, Matteo: 1 article (11/2010)|
|7.||Da Settimo, Federico: 1 article (11/2010)|
|8.||Ghisu, Narcisa: 1 article (11/2010)|
|9.||Natale, Gianfranco: 1 article (11/2010)|
|10.||La Motta, Concettina: 1 article (11/2010)|
11/01/1983 - "Effect of adenosine deaminase inhibitors on the heart's functional and biochemical recovery from ischemia: a study utilizing the isolated rat heart adapted to 31P nuclear magnetic resonance."
12/01/1997 - "In the isolated rat heart model of ischemia, these novel ADA inhibitors showed enhanced recovery of left ventricular end-diastolic pressure, left ventricular developed pressure, +dP/dtmax and -dP/dtmax. "
11/01/1983 - "Thus, these adenosine deaminase inhibitors improve functional recovery following ischemia, although this improvement was not well correlated with purine losses observed during reperfusion."
11/01/1983 - "The adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2'-deoxycoformycin (DCF) were given 5 min before ischemia and for the first 5 min of reperfusion. "
|2.||T-Cell Lymphoma (Lymphoma, T Cell)
03/01/1978 - "Using the S49 T-cell lymphoma system for the study of immunodeficiency diseases, we characterized several variants in purine salvage and transport pathways and studied their responses to the cytotoxic action of adenosine (5-20 micron) in the presence of adenosine deaminase (ADA) inhibitors. "
11/01/2010 - "The present results show that: 1) bowel inflammation is associated with an enhanced adenosine deaminase expression; and 2) the anti-inflammatory actions of adenosine deaminase inhibitors against chronic established colitis depend on the sparing of endogenous adenosine, leading to enhanced A(2A) and A(3) receptor activation."
11/01/2010 - "This study investigates the expression of adenosine deaminase in the inflamed colon, the effects of adenosine deaminase inhibitors on established colitis, and the recruitment of adenosine receptors by endogenous adenosine after adenosine deaminase blockade. "
|4.||B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/01/2003 - "Adenosine deaminase inhibitors have proven superior to alkylating agent-based therapies in inducing clinical and hematologic remissions in treated and previously untreated chronic lymphocytic leukemia (CLL) patients, and they have become increasingly accepted as a standard for therapy. "
07/01/1983 - "These results may serve as the basis for further pharmacologic investigations of adenosine and adenosine deaminase inhibitors in chronic lymphocytic leukemia."
09/01/1986 - "It is identical to the activity of C57BL/6 thymic cells or C57BL/6 T tumor lines regarding its sensitivity to ADA inhibitors 2-deoxycoformycin and erythro-9-(2-hydroxyl-3-nonyl)adenine, and its electrophoretic mobility under nondenaturing conditions (starch gel and isoelectric focusing). "
01/01/1988 - "The simultaneous administration of 3'-deoxyadenosine N1-oxide (3'-dANO) and the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) or 2'-deoxycoformycin (2'-dCF) to mice bearing Ehrlich ascites tumor cells resistant to 3'-dANO resulted in 80%-90% inhibition of tumor growth in vivo. "
|4.||Purinergic P1 Receptors (Adenosine Receptor)
|1.||Transplantation (Transplant Recipients)